Healthcare - Sector
Magenta Therapeutics's activity chart (see below) currently has 37 price targets and 34 ratings on display.
Analysts' price targets on this stock were met 45.83% of the time, taking 156.88 days on average.
Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 16-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Jun-2021
$50
3 years 9 months 25 days ago
(26-Jan-2023)
0/4 (0%)
$43.72 (696.18%)
Buy Since 16-Jul-2018
$144
3 years 9 months 25 days ago
(26-Jan-2023)
0/3 (0%)
$100.32 (229.67%)
Buy Since 08-Mar-2022
$2
4 years 2 months 26 days ago
(25-Aug-2022)
1/2 (50%)
$-16.72 (-89.32%)
287
Buy Since 06-Jan-2021
$8
$272
4 years 7 months 2 days ago
(18-Apr-2022)
1/3 (33.33%)
$-22.72 (-73.96%)
246
Buy Since 01-Dec-2021
$128
$272
4 years 7 months 6 days ago
(14-Apr-2022)
0/2 (0%)
$92.16 (257.14%)
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MGTA (Magenta Therapeutics)?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?